Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis

OBJECTIVE: To investigate treatment patterns in patients with rheumatoid arthritis (RA) in Germany who had previously received conventional synthetic (cs) or biologic (b) disease-modifying antirheumatic drugs (DMARDs). METHODS: Patients with RA who initiated treatment with a csDMARD, bDMARD, or Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiehn, Christoph, Zinke, Silke, Haas, Jennifer S., Meise, Dominic, Theil, Julia, Gurrath, Margot, Orzechowski, Hans-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2023
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627963/
https://www.ncbi.nlm.nih.gov/pubmed/36757417
http://dx.doi.org/10.1007/s00393-023-01323-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627963/
https://www.ncbi.nlm.nih.gov/pubmed/36757417
http://dx.doi.org/10.1007/s00393-023-01323-8

Ejemplares similares